The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome

Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome

June 12, 2016 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Disease remission in patients with rheumatoid arthritis (RA) is associated with a lower risk of developing metabolic syndrome, according to a new study from Thailand.

You Might Also Like
  • Rheumatoid Arthritis Risk Lower Among Smokers Who Quit
  • Rheumatoid Arthritis Prevention, Remission & Treatment De-Escalation
  • Metabolic Syndrome Linked to Higher Risk for Immunological Disorders

Researchers also found that a lower educational level was linked to a higher risk of metabolic syndrome, they report in Joint Bone Spine, online May 26.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Wanruchada Katchamart and colleagues at Siriraj Hospital in Bangkok analyzed data prospectively collected since 2011 in the hospital’s RA registry. Their analysis covers 267 patients with complete data on disease activity, functional status, and metabolic syndrome parameters as of February 2015. Most patients (88%) were female and the mean age was 59.

The researchers found that 43 RA patients (16%) also had metabolic syndrome. Using backward stepwise logistic regression analysis, they identified three factors independently associated with metabolic syndrome: higher BMI (odds ratio, 1.2; p<0.001), education level 12 years or less (OR, 5.92; p=0.01), and disease remission (OR, 0.11; p=0.04).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Patients with metabolic syndrome had a higher proportion of rituximab use than those without the syndrome (OR, 17.44; p=0.002).

The education-level finding has not been shown in previous research, the authors noted. “Patient education involving lifestyle modification should be routinely implemented in the daily practice,” they write.

The most prevalent component of metabolic syndrome was hypertension, with 90.7% of patients with metabolic syndrome having elevated blood pressure, compared with 57.1% of those without the syndrome.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

One strength of the study is having a higher number of patients than previous research, the researchers say, while a limitation is that patients were seen at a tertiary care center and may have had more severe disease than RA patients in general.

The team concludes, “These findings suggest that low cumulative disease activity may decrease risk for (metabolic syndrome). Annual surveillance of (metabolic syndrome) should be considered in all patients with RA. In addition, suppression of disease activity to at least low disease activity or remission is beneficial for not only preventing joint deformities and functional disability, but also reducing the risk of (metabolic syndrome) leading to lower (cardiovascular) morbidity and mortality.”

Dr. Katchamart did not respond to a request for comment.

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: metabolic syndrome, Remission, Rheumatoid Arthritis (RA), rituximab

You Might Also Like:
  • Rheumatoid Arthritis Risk Lower Among Smokers Who Quit
  • Rheumatoid Arthritis Prevention, Remission & Treatment De-Escalation
  • Metabolic Syndrome Linked to Higher Risk for Immunological Disorders
  • EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.